NewslettersCell Therapy NewsBioactive-Material-Programmed CAR-T Cell Living Drug for Augmented Immunotherapy against TumorsBy lbeveridge - June 10, 20240264Investigators summarize the use of bioactive-material-programmed CAR-T cells for disrupting tumor microenvironment barriers by modulating the immunosuppressive microenvironment, thus avoiding the side effects.[Cell Reports Physical Science]Full Article